|

Thalidomide Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Sarcoma Oncology Research Center, LLC1
  • Medical University of Vienna1
  • Fudan University1

Indications

  • Cancer3
  • Rare CNS Tumor Recurrent1
  • ATRT Recurrent1
  • Ependymoma Recurrent1
  • Chemotherapy Induced Nausea and Vomiting1

Other1 trial

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Phase 3

Santa Monica, California1 trial

Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

Sarcoma Oncology Research Center / Cancer Center of Southern California

Phase 2

Chicago, Illinois1 trial

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Ann & Robert H. Lurie Children's Hospital of Chicago

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.